Prevalence of chronic obstructive pulmonary disease (COPD) in Greece Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002
Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007
Awareness of chronic obstructive pulmonary disease (COPD) in Portugal general practicioners Source: Eur Respir J 2007; 30: Suppl. 51, 129s Year: 2007
Prevalence of chronic obstructive pulmonary disease (COPD) in primary care Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008
Chronic obstructive pulmonary disease (COPD) and medicine comsumption in Italian general population samples Source: Eur Respir J 2002; 20: Suppl. 38, 125s Year: 2002
The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007
Treatment patterns of patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
COPD exacerbations in patients with chronic obstructive pulmonary disease in general practice in Ireland Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013
Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008
Chronic bronchitis among French adults: high prevalence and underdiagnosis Source: Eur Respir J 2002; 20: 806-812 Year: 2002
Characteristics and comorbidities associated with pain in people with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Functional illiteracy amongst those with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005
Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015
The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012
Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021
The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study Source: Eur Respir J 2012; 40: 28-36 Year: 2012
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016